Consolidated Cash Flow Statement

Profit after tax

Depreciation/amortization/impairment losses/reversals of impairment losses

Changes in inventories

Changes in trade accounts receivable

Changes in trade accounts payable/refund liabilities

Changes in provisions

Changes in other assets and liabilities

Neutralization of gains/losses on disposal of fixed assets and other disposals

Other non-cash income and expenses

Net cash flows from operating activities

thereof: from discontinued operations

Payments for investments in intangible assets

Payments from the disposal of intangible assets

Payments for investments in property, plant and equipment

Payments from the disposal of property, plant and equipment

Payments for investments in financial assets

Payments for acquisitions less acquired cash and cash equivalents (net)

Proceeds from the disposal of other financial assets

Payments for the acquisition of non-financial assets

Proceeds from the disposal of non-financial assets

Payments for the disposal of assets held for sale

Proceeds from the disposal of assets held for sale less transferred cash and cash equivalents

Net cash flows from investing activities

thereof: from discontinued operations

Dividend payments to shareholders of Merck KGaA, Darmstadt, Germany

Dividend payments to non-controlling interests

Profit withdrawal by E. Merck KG, Darmstadt, Germany

Proceeds from new borrowings of financial debt from E. Merck KG, Darmstadt, Germany

Repayment of financial debt to E. Merck KG, Darmstadt, Germany

Repayment of bonds

Proceeds from the issuance of bonds

Payments from new borrowings of other current and non-current financial debt

Repayment of other current and non-current financial debt

Net cash flows from financing activities

thereof: from discontinued operations

Changes in cash and cash equivalents

Changes in cash and cash equivalents due to currency translation

Cash and cash equivalents as of January 1

Cash and cash equivalents as of December 31 (consolidated balance sheet)